OTCMKTS:IMUC EOM Pharmaceutical (IMUC) Stock Price, News & Analysis $0.16 0.00 (0.00%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About EOM Pharmaceutical Stock (OTCMKTS:IMUC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EOM Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.16▼$0.1650-Day Range$0.11▼$0.2452-Week Range$0.02▼$0.34Volume8 shsAverage Volume3,635 shsMarket Capitalization$20.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Publicly available records primarily associate the OTC Markets symbol IMUC with ImmunoCellular Therapeutics, Ltd., a biotechnology company that researched cancer immunotherapies. Its development programs included investigational treatments designed to stimulate the immune system to recognize and attack tumor cells, including vaccine-based approaches for brain cancer. Information confirming a current operating company named EOM Pharmaceutical under the IMUC symbol is limited. The available historical record does not provide sufficient reliable detail about EOM Pharmaceutical’s present products, geographic operations, or leadership to support a more complete company description.AI Generated. May Contain Errors. Read More Receive IMUC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EOM Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMUC Stock News HeadlinesEom Pharmaceutical Holdings Stock Price HistorySeptember 2, 2026 | investing.comEOM Pharmaceutical Holdings Inc (IMUC) Real-TimeMay 27, 2026 | nasdaq.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.October 4 at 1:00 AM | Profits Run (Ad)Eom Pharmaceutical Holdings IncMay 27, 2026 | cnbc.comEOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer PatientsMay 27, 2026 | markets.businessinsider.comEOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147January 7, 2026 | tmcnet.comQ32 Bio Inc. R (DB0.BE)January 15, 2025 | finance.yahoo.comImmunoCellular Therapeutics, Ltd. (IMUC)January 5, 2024 | uk.finance.yahoo.comSee More Headlines IMUC Stock Analysis - Frequently Asked Questions How have IMUC shares performed this year? EOM Pharmaceutical's stock was trading at $0.0710 on January 1st, 2026. Since then, IMUC stock has increased by 123.8% and is now trading at $0.1589. How were EOM Pharmaceutical's earnings last quarter? EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC) released its quarterly earnings data on Monday, August, 13th. The company reported ($0.01) EPS for the quarter. How do I buy shares of EOM Pharmaceutical? Shares of IMUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EOM Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that EOM Pharmaceutical investors own include Argos Therapeutics (ARGSQ), Nightfood (NGTF), Meta Platforms (META), Inovio Pharmaceuticals (INO), MannKind (MNKD) and Agenus (AGEN). Company Calendar Last Earnings8/13/2018Today10/04/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:IMUC CIK822411 Webeompharma.com Phone(201) 351-0605Fax818-224-5287Employees3Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares126,500,000Free Float122,354,000Market Cap$20.10 million OptionableNot Optionable Beta0.11 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:IMUC) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EOM Pharmaceutical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EOM Pharmaceutical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
